The technology is being used in the manufacturing of HemoBioTech’s lead product HemoTech, potentially the first viable substitute for human blood. HemoTech is composed of chemically modified bovine
James Mack, president and CEO since 1995 and chairman since 1999, has announced he will step down. The company will separate the positions of board chairman and CEO
The company expects to begin shipping immediately. This product is a generic version of AstraZeneca’s branded product, Toprol-XL. Metoprolol succinate extended-release tablets are indicated for the treatment of
Coupled together with the Situs OTW left ventricle pacing lead, this device will now allow US physicians to treat their heart failure patients with a complete Sorin Group
Mr Ellberger succeeds Fredric Price who served as Omrix’s chairman from January 2005. Mr Ellberger has been a member of the company’s board since August 2006 and was
The applications were submitted using the decentralized process with the UK serving as the reference member state. With the validation, the agencies will begin their formal review of
The interim findings from first Phase of the study suggested that the vaccine is well tolerated and immunogenic at the 15 microgram and 45 microgram dose levels. Based
The AVP III is a self-expanding nitinol mesh device and is designed to be introduced in a minimally invasive fashion through a catheter. The AVP III is under
In this role, Gontarek will oversee the operations of the company’s more than 45 diagnostic imaging centers across the country. Most recently, he served as executive vice president
The trials, which will begin during the second half of 2008, will test AZD6244 (ARRY-886) in combination with a cytotoxic chemotherapeutic agent; one trial will be in melanoma
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.